Literature DB >> 31506700

Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America.

Lindsay E Nicolle1, Kalpana Gupta2, Suzanne F Bradley3, Richard Colgan4, Gregory P DeMuri5, Dimitri Drekonja6, Linda O Eckert7, Suzanne E Geerlings8, Béla Köves9, Thomas M Hooton10, Manisha Juthani-Mehta11, Shandra L Knight12, Sanjay Saint13, Anthony J Schaeffer14, Barbara Trautner15, Bjorn Wullt16, Reed Siemieniuk17.   

Abstract

Asymptomatic bacteriuria (ASB) is a common finding in many populations, including healthy women and persons with underlying urologic abnormalities. The 2005 guideline from the Infectious Diseases Society of America recommended that ASB should be screened for and treated only in pregnant women or in an individual prior to undergoing invasive urologic procedures. Treatment was not recommended for healthy women; older women or men; or persons with diabetes, indwelling catheters, or spinal cord injury. The guideline did not address children and some adult populations, including patients with neutropenia, solid organ transplants, and nonurologic surgery. In the years since the publication of the guideline, further information relevant to ASB has become available. In addition, antimicrobial treatment of ASB has been recognized as an important contributor to inappropriate antimicrobial use, which promotes emergence of antimicrobial resistance. The current guideline updates the recommendations of the 2005 guideline, includes new recommendations for populations not previously addressed, and, where relevant, addresses the interpretation of nonlocalizing clinical symptoms in populations with a high prevalence of ASB.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  asymptomatic bacteriuria; bacteriuria; cystitis; diabetes; endourologic surgery; long-term care; neurogenic bladder; nursing home; older adults; pregnancy; pyelonephritis; renal transplant; spinal cord injury; urinary catheter; urinary tract infection; urologic devices

Mesh:

Substances:

Year:  2019        PMID: 31506700     DOI: 10.1093/cid/ciz021

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  35 in total

1.  Asymptomatic Bacteriuria versus Symptom Underreporting in Older Emergency Department Patients with Suspected Urinary Tract Infection.

Authors:  Jeffrey M Caterino; Julie A Stephens; Carlos A Camargo; Randell Wexler; Courtney Hebert; Lauren T Southerland; Katherine M Hunold; David S Hains; Jason J Bischof; Lai Wei; Alan J Wolfe; Andrew Schwaderer
Journal:  J Am Geriatr Soc       Date:  2020-08-17       Impact factor: 5.562

2.  Efficacy and safety of oral fosfomycin for asymptomatic bacteriuria in kidney transplant recipients: Results from a Spanish multicenter cohort.

Authors:  María Ruiz-Ruigómez; Mario Fernández-Ruiz; José Tiago Silva; Elisa Vidal; Julia Origüen; Antonia Calvo-Cano; Enrique Luna-Huerta; Esperanza Merino; Domingo Hernández; Cristina Jironda-Gallegos; Rosa Escudero-Sánchez; Francesca Gioia; Antonio Moreno; Cristina Roca; Elisa Cordero; Darío Janeiro; Beatriz Sánchez-Sobrino; María Milagro Montero; Dolores Redondo; Francisco Javier Candel; Isabel Pérez-Flores; Carlos Armiñanzas; Claudia González-Rico; María Carmen Fariñas; Emilio Rodrigo; Belén Loeches; María O López-Oliva; Miguel Montejo; Ricardo Lauzurica; Juan Pablo Horcajada; Julio Pascual; Amado Andrés; José María Aguado; Francisco López-Medrano
Journal:  Antimicrob Agents Chemother       Date:  2021-02-08       Impact factor: 5.191

3.  Infectious complications of prostate biopsy: winning battles but not war.

Authors:  Okan Derin; Limírio Fonseca; Rafael Sanchez-Salas; Matthew J Roberts
Journal:  World J Urol       Date:  2020-02-24       Impact factor: 4.226

Review 4.  Targeting Asymptomatic Bacteriuria in Antimicrobial Stewardship: the Role of the Microbiology Laboratory.

Authors:  Zanthia Wiley; Jesse T Jacob; Eileen M Burd
Journal:  J Clin Microbiol       Date:  2020-04-23       Impact factor: 5.948

5.  Quality Improvement Interventions and Implementation Strategies for Urine Culture Stewardship in the Acute Care Setting: Advances and Challenges.

Authors:  Sonali Advani; Valerie M Vaughn
Journal:  Curr Infect Dis Rep       Date:  2021-08-26       Impact factor: 3.725

Review 6.  Contemporary management considerations of urinary tract infections for women with spina bifida.

Authors:  Ellen Fremion; Paola Bustillos; Rose Khavari
Journal:  Int Urogynecol J       Date:  2021-06-03       Impact factor: 2.894

7.  Role of asymptomatic bacteriuria on early periprosthetic joint infection after hip hemiarthroplasty. BARIFER randomized clinical trial.

Authors:  Dolors Rodríguez-Pardo; María Dolores Del Toro; Laura Guío-Carrión; Rosa Escudero-Sánchez; Marta Fernández-Sampedro; Miguel Ángel García-Viejo; María Velasco-Arribas; Laura Soldevila-Boixader; Magdalena Femenias; José Antonio Iribarren; María Del Carmen Pulido-Garcia; María Dolores Navarro; Mayli Lung; Pablo S Corona; Benito Almirante; Carles Pigrau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-04-16       Impact factor: 3.267

8.  Predictors of potentially suboptimal treatment of urinary tract infections in long-term care facilities.

Authors:  H J Appaneal; A R Caffrey; V V Lopes; V Mor; D M Dosa; K L LaPlante; T I Shireman
Journal:  J Hosp Infect       Date:  2021-02-05       Impact factor: 3.926

9.  Examining primary care physician rationale for not following geriatric choosing wisely recommendations.

Authors:  Theresa A Rowe; Tiffany Brown; Jason N Doctor; Jeffrey A Linder; Stephen D Persell
Journal:  BMC Fam Pract       Date:  2021-05-15       Impact factor: 2.497

10.  Investigation and treatment of asymptomatic bacteriuria in older patients with delirium: a cross-sectional survey of Canadian physicians.

Authors:  Antoine Laguë; Valérie Boucher; Pil Joo; Krishan Yadav; Charles Morasse; Marcel Émond
Journal:  CJEM       Date:  2021-06-28       Impact factor: 2.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.